Pregnancy-associated plasma protein-A expression in human breast cancer

Growth Hormone and IGF Research

Volumn 24, Issue 6, 2014, Pages 264-267

  Mansfield, Aaron S ^a   Visscher, Daniel W ^b   Hart, Steven N ^a   Wang, Chen ^a   Goetz, Matthew P ^a   Oxvig, Claus ^c   Conover, Cheryl A ^d  

^a Department of Laboratory Medicine ^*  (United States)

^b Division of Oncology Research   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d MAYO CLINIC   (United States)

Author keywords

Breast cancer; Immunohistochemistry; Pregnancy associated plasma protein A

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROGESTERONE RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; PAPPA1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR DIAGNOSIS; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH; BREAST TUMOR; ENZYME IMMUNOASSAY; LUNG CARCINOMA; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PREGNANCY; PROGNOSIS;

AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84919474294     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2014.10.007     Document Type: Article

References (24)

1. Lin T.M., Galbert S.P., Kiefer D., Spellacy W.N., Gall S. Characterization of four human pregnancy-associated plasma proteins. Am. J. Obstet. Gynecol. 1974, 118:223-236.
2. Conover C.A. Key questions and answers about pregnancy-associated plasma protein-A. Trends Endocrinol. Metab. 2012, 23:242-249.
3. Samani A.A., Yakar S., LeRoith D., Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr. Rev. 2007, 28:20-47.
4. Bulut I., Coskun A., Ciftci A., Cetinkaya E., Altiay G., Caglar T., Gulcan E. Relationship between pregnancy-associated plasma protein-A and lung cancer. Am. J. Med. Sci. 2009, 337:241-244.
5. Alexiadis M., Mamers P., Chu S., Fuller P.J. Insulin-like growth factor, insulin-like growth factor-binding protein-4, and pregnancy-associated plasma protein-A gene expression in human granulosa cell tumors. Int. J. Gynecol. Cancer 2006, 16:1973-1979.
6. Boldt H.B., Conover C.A. Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo. Endocrinology 2011, 152:1470-1478.
7. Pan H., Hanada S., Zhao J., Mao L., Zhi-Qing Ma M. Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo. PLoS One 2012, 7:e4799.
8. Tanaka Y., Jobayashi H., Suzuki M., Hirashima Y., Kanayama N., Terao T. Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis. Int. J. Cancer 2004, 109:336-347.
9. Huang J., Tabata S., Kakiuchi S., The Van T, Goto H., Hanibuchi M., Nishioka Y. Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target. Oncotarget 2013, 4:1172-1184.
10. Surmacz E. Function of the IGF-1 receptor in breast cancer. J. Mammary Gland Biol. Neoplasia 2000, 5(1):95-105.
11. Kuhajda F.P., Eggleston J.C. Pregnancy-associated plasma protein A. A clinically significant predictor of early recurrence in stage I breast carcinoma is independent of estrogen receptor status. Am. J. Pathol. 1985, 121:342-348.
12. Ryan A.J., Napoletano S., Fitzpatrick P.A., Currid C.A., O'Sullivan N.C., Harmey J.H. Expression of a protease-resistant insulin-like growth factor binding protein-4 inhibits tumor growth in a murine model of breast cancer British. J. Cancer Educ. 2009, 101:278-286.
13. Loddo M., Andryszkiewicz J., Rodriguez-Acebes S., Stoeber K., Jones A., Dafou D., Apostolidou S., Wollenschlaeger A., Widschwerndter M., Sainsbury R., Tudzarova S., Williams G.H. Pregnancy-associated plasma protein A regulates mitosis and is epigenetically silenced in breast cancer. J. Pathol. 2014, 233:344-356.
14. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes D.R., Virmani R., Oxvig C., Schwartz R.S. Pregnancy-associated plasma protein-A and diagnosis of acute coronary syndromes. N. Engl. J. Med. 2001, 345:1022-1029.
15. Chen B.-K., Leiferman K.M., Pittelkow M.R., Overgaard M.T., Oxvig C., Conover C.A. Localization and regulation of pregnancy associated plasma protein-A expression in healing human skin. J. Clin. Endocrinol. Metab. 2003, 88:4465-4471.
16. Mikkelsen J.H., Steffensen L.B., Oxvig C. Development of a recombinant antibody towards PAPP-A for immunohistochemical use in multiple animal species. J. Immunol. Methods 2014, 404:33-40.
17. Cheang M.C., Chia S.K., Voduc D., Gao D., Leung S., Snider J., Watson M., Davies S., Bernard P.S., Parker J.S., Perou C.M., Ellis M.J., Nielsen T.O. Ki index, HER2 status, and prognosis of patients with luminal B cancer. J. Natl. Cancer Inst. 2009, 101:736-750.
18. Creighton C.J. The molecular profile of luminal B breast cancer. Biologics 2012, 6:289-297.
19. Kuhajda F.P., Katumuluwa A.I., Pasternack G.R. Expression of haptoglobin-related protein and its potential role as a tumor antigen. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:1188-1192.
20. Bukowski R., Chlebowski R.T., Thune I., Furberg A.S., Hankins G.D., Malone F.D., D'Alton M.E. Birth weight, breast cancer and the potential mediating hormonal environment. PLoS One 2012, 7:e40199.
21. Chander H., Halpern M., Resnick-Silverman L., Manfredi J.J., Germain D. Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4. PLoS One 2011, 6:e22456.
22. Prager D., Li H.L., Asa S., Melmed S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2181-2185.
23. Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat. Rev. Cancer 2012, 12:159-169.
24. Mikkelsen J.H., Resch Z.T., Kalra B., Savjani G., Kumar A., Conover C.A., Oxvig C. Indirect targeting of IGF receptor signaling in vivo by substrate selective inhibition of PAPP-A proteolytic activity. Oncotarget 2014, 5:1014-1025.